Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $534.21 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $209.60 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $65.39 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $50.24 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $47.54 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $44.22 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $39.20 | 2 | $0 (2024) |
| ABBVIE INC. | $24.60 | 2 | $0 (2022) |
| Indivior Inc. | $23.15 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $17.21 | 1 | $0 (2021) |
| ITI, Inc. | $13.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.99 | 12 | Alkermes, Inc. ($209.60) |
| 2023 | $118.41 | 7 | Teva Pharmaceuticals USA, Inc. ($50.24) |
| 2022 | $13.38 | 1 | ABBVIE INC. ($13.38) |
| 2021 | $28.43 | 2 | Sunovion Pharmaceuticals Inc. ($17.21) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $64.00 | General |
| Category: CNS | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: CNS | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $65.39 | General |
| 09/04/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $102.63 | General |
| Category: CNS | ||||||
| 09/03/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: OUD | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Neuroscience | ||||||
| 07/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CNS | ||||||
| 05/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: CNS | ||||||
| 04/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Neuropsychiatry | ||||||
| 02/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neuropsychiatry | ||||||
| 01/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Central Nervous System | ||||||
| 08/30/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/25/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Central Nervous System | ||||||
| 06/14/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Central Nervous System | ||||||
| 03/08/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Neuroscience | ||||||
| 01/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 88 | 300 | $16,751 | $8,671 |
| 2022 | 3 | 93 | 265 | $14,127 | $6,746 |
| 2021 | 3 | 126 | 421 | $20,753 | $11,923 |
| 2020 | 2 | 131 | 517 | $25,860 | $13,435 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 169 | $12,332 | $6,145 | 49.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 24 | 71 | $1,851 | $1,265 | 68.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 60 | $2,568 | $1,261 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 140 | $10,216 | $4,679 | 45.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 27 | 86 | $2,242 | $1,369 | 61.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 39 | $1,669 | $697.62 | 41.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 191 | $13,937 | $7,518 | 53.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 47 | 181 | $4,719 | $3,346 | 70.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 49 | $2,097 | $1,059 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 264 | $19,264 | $8,463 | 43.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 64 | 253 | $6,596 | $4,972 | 75.4% |
About Lora Morehead
Lora Morehead is a Professional healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1356751820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lora Morehead has received a total of $534.21 in payments from pharmaceutical and medical device companies, with $373.99 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($534.21).
As a Medicare-enrolled provider, Morehead has provided services to 438 Medicare beneficiaries, totaling 1,503 services with total Medicare billing of $40,776. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Professional
- Other Specialties Family
- Location Charleston, WV
- Active Since 05/05/2014
- Last Updated 08/27/2024
- Taxonomy Code 101YP2500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356751820
Products in Payments
- LYBALVI (Drug) $166.63
- Austedo XR (Drug) $50.24
- INGREZZA (Drug) $47.54
- ARISTADA (Drug) $42.97
- ABILIFY ASIMTUFII (Drug) $31.08
- VRAYLAR (Drug) $24.60
- SPRAVATO (Drug) $24.03
- SUBLOCADE (Drug) $23.15
- LATUDA (Drug) $17.21
- INVEGA SUSTENNA (Drug) $15.17
- ABILIFY MAINTENA (Drug) $13.14
- CAPLYTA (Drug) $13.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Professional Doctors in Charleston
Mrs. Beverly Voris, Lcpc, LCPC
Professional
Mrs. Jean Elliott, M.ed., Lpc, Ncc, Rpt, M.ED., LPC, NCC, RPT
Professional
Jacquelyn Mcdonald, Lpc, LPC
Professional
Wendy Molinaroli, M.ed, Lpc, Ncc, M.ED, LPC, NCC
Professional
Corinne Mauldin, L P C, L P C
Professional
Mrs. Laura Blake, Lpc, LPC
Professional